ARCHIVES

BMS Settles Charges Of Obstructing Generics

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Subcommittee Adds $100 Million For NCI Over House Bill, No Further Action Until Sept.

August 8, 1975

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

Higgins: VA Groups D Have Review; NCI: It’s Ad Hoc

December 2, 1977

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

Sentinel Node Disection No Worse Than Axillary

February 25, 2011